MEDARTIS: Very reassuring operational performance in H2 2019 | BUY | CHF64(+58%)
MEDARTIS - BUY | CHF64(+58%)Very reassuring operational performance in H2 2019
Good growth in 2019, supported by strong H2 figures
EMEA remains Medartis’ main driver
US region will be a major area of focus in 2020
Launches, M&A and management focus to drive growth
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.